Press Release | June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Read More
Press Release | June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Read More
News | June 3, 2020
Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline
Read More
Press Release | May 28, 2020
Palvella Therapeutics Completes $45 Million Series C Financing
Read More
